Force Load Font
For the treatment of facial hirsutism in women
Female Hair Hirsutism
Eflornithine Hydrochloride 11.5%
Warnings and Contraindications
Vaniqa is for cutaneous use only. Contact with eyes or mucous membranes (e.g. nose or mouth) should be avoided.
Transient stinging or burning may occur when the cream is applied to abraded or broken skin.
Do not use in the case of hypersensitivity to the active ingredient or to any of the additional ingredients.
Common Side Effects
Acne, alopecia, stinging skin, burning skin, dry skin, pruritus, erythema, tingling skin, irritated skin, rash, folliculitis
This medicinal product contains cetostearyl alcohol and stearyl alcohol which may cause local skin reactions (e.g. contact dermatitis) as well as methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions.
Cetostearyl alcohol; Macrogol cetostearyl ether; Dimeticone; Glyceryl stearate; Macrogol stearate; Methyl parahydroxybenzoate (E218);
Liquid paraffin; Phenoxyethanol; Propyl parahydroxybenzoate (E216); Purified water; Stearyl alcohol; Sodium hydroxide (E524) (to adjust pH)
Vaniqa cream should be applied to the affected area twice daily, at least eight hours apart. Application should be limited to affected areas of the face and under the chin
Do not store above 25°C
Improvement in the condition may be noticed within eight weeks of starting treatment. Continued treatment may result in further improvement and maintain beneficial effects. The condition may return eight weeks after stopping treatment.
If skin irritation or intolerance develops, the frequency of application should be reduced temporarily to once a day. If irritation continues, treatment should be discontinued
Download Patient Information Leaflet
Add to Bag
Finish, choose your treatment below
RETURNS AND REFUND POLICY
49-51 Crow Road, Glasgow, G11 7SH
Place of registration:
124 City Road, London EC1V 2NX